1 citations,
October 2023 in “Frontiers in endocrinology” Regulating certain sex hormones may help delay facial aging.
November 2023 in “The journal of investigative dermatology/Journal of investigative dermatology” Combining stem cell exosomes with microneedling improves facial skin aging effectively and safely.
August 2023 in “British journal of dermatology/British journal of dermatology, Supplement” Rubbing or pressing on the face can cause small bumps, and changing posture along with certain creams can improve them.
January 2023 in “Bio web of conferences/BIO web of conferences” The document concludes that specific dermoscopic features can help diagnose different facial red skin conditions.
June 2017 in “Journal of The American Academy of Dermatology” Women in Australia report different signs of facial aging compared to women in the US, UK, and Canada; men with Lichen planopilaris often have hormonal abnormalities and thyroid disease.
January 2016 in “Georg Thieme Verlag eBooks” Tailoring facelift techniques to individual needs improves patient satisfaction.
Botulinum toxin-A injections in the scalp can reduce hair loss and promote new hair growth in men with certain types of baldness.
August 2009 in “Journal of Oral and Maxillofacial Surgery” Hair transplantation and micrografting are effective for facial enhancement with nearly 100% graft survival when done carefully.
32 citations,
January 2010 in “Dermatology” Combining laser hair removal with topical eflornithine is recommended for better results in treating unwanted facial hair.
25 citations,
April 2019 in “Journal of The American Academy of Dermatology” Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.
14 citations,
December 2013 in “Experimental Dermatology” The T-zone on the face has more androgen receptors and produces more oil than the U-zone.
2 citations,
January 2023 in “BioMed Research International” The secretome from mesenchymal stromal cells shows promise for improving facial nerve injury treatment.
1 citations,
July 2022 in “Functional foods in health and disease/Journal of functional foods in health & disease” Taking a probiotic supplement twice a day improved hair growth, skin hydration, and metabolic health in adults at risk of metabolic syndrome.
1 citations,
September 2016 in “PubMed” Using finasteride 0.5% solution with laser therapy significantly reduces unwanted facial hair in women.
November 2023 in “Research Square (Research Square)” NIR-II imaging effectively tracked stem cells that helped repair facial nerve defects in rats.
August 2023 in “Theoretical and Natural Science” Fat stem cells help rejuvenate skin, reduce wrinkles, lighten skin, and promote hair growth.
August 2022 in “Dermatology Online Journal” Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.
March 2022 in “Folia Medica Indonesiana” The lump on a woman's scalp was a rare, potentially cancerous tumor from the hair follicle, not a common cyst.
October 2006 in “Dermatologic Surgery” The study assessed the efficacy and safety of combining eflornithine cream with laser therapy for unwanted facial hair in women. Fifty-four women participated, with eflornithine applied to one side of the face and a vehicle to the other, alongside laser treatments at Weeks 2 and 10. Results showed significant hair reduction on eflornithine-treated sides from Weeks 6 to 22, with persistent reduction noted by subjects through Week 34. The combination therapy was as safe as eflornithine alone and enhanced hair removal speed. Participants preferred the combination of laser and eflornithine treatment.
18 citations,
October 2015 in “Journal of the European Academy of Dermatology and Venereology” This study investigated the effectiveness of topical eflornithine in maintaining hair reduction in women with facial hirsutism following intense pulsed light (IPL) therapy. Conducted as a randomized, split-face, single-blinded controlled trial, it involved 22 women, with 18 completing the study. Eflornithine was applied twice daily for 6 months to half of the face after 5-6 IPL treatments. Results showed that eflornithine reduced hair regrowth by 14% at 1 month, 9% at 3 months, and 17% at 6 months compared to no treatment. Patients reported satisfaction with the treatment, although two experienced worsening acne. Overall, eflornithine was well tolerated and showed potential as a self-administered option to maintain IPL-induced hair reduction.
3 citations,
January 2019 in “Aesthetic Surgery Journal” Google Trends is useful for aesthetic surgeons to improve marketing by tracking what and when people search for facial cosmetic procedures.
125 citations,
February 2007 in “Journal of the American Academy of Dermatology” 3 citations,
January 2000 in “Current Medical Research and Opinion” Eflornithine HCl 13.9% cream (Vaniqa™) was evaluated for dermal safety in four studies involving 230 subjects. The cream caused erythema with oedema in 38.9% of subjects, compared to 4.8% with the vehicle cream. In a cumulative irritation study with 30 subjects, the cream had a mean irritation score of 1.33, lower than the positive control but higher than the vehicle. Phototoxicity and photocontact allergy studies showed mild or no reactions, with effects subsiding within 24 hours. No serious adverse events were reported, and the cream did not exhibit contact sensitizing, photocontact allergic, or phototoxic properties. It was deemed to have a favorable dermal safety profile for routine use.
October 2024 in “Skin Appendage Disorders” PRP is popular for hair restoration but needs better research methods to confirm its effectiveness and safety.
August 2018 in “Journal of The American Academy of Dermatology” The moisturizing cream used after a chemical peel was well tolerated and effectively moisturized the skin.
December 2022 in “Stem Cells and Development” Exosomes from stem cells help improve nerve repair in rats.
133 citations,
July 2006 in “International Journal of Dermatology” The study conducted a randomized, double-blind clinical trial to evaluate the efficacy and safety of topical eflornithine HCl 13.9% cream for treating facial hair in women. The results demonstrated that the cream was effective in reducing facial hair growth. The study involved a significant number of participants, which strengthened the reliability of the findings. The treatment was generally well-tolerated, with minimal adverse effects reported, indicating that eflornithine HCl 13.9% cream was a safe and effective option for managing unwanted facial hair in women.
13 citations,
July 2004 in “Pediatric dermatology” A new severe form of monilethrix syndrome includes hair loss, scalp itching, cataracts, and distinct facial features.
January 2024 in “Aging medicine” A COVID-19 infected patient with chronic kidney disease experienced worsened kidney function, hair loss, and unexpected wart clearance.
Processed fat, SVF, and PRP are safe and effective for facial rejuvenation and hair growth.